Literature DB >> 23566971

Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma.

Stephen R Broderick1, G Alexander Patterson.   

Abstract

Integrated positron emission tomography (PET)/CT is routinely used for mediastinal nodal staging of non-small cell lung carcinoma in centers throughout the world. This modality is the most accurate noninvasive means by which to identify metastatic disease in mediastinal lymph nodes. This article reviews the evidence supporting the use of PET/CT and discusses the clinical applicability of this modality.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23566971     DOI： 10.1016/j.thorsurg.2013.01.014

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  11 in total

1.  Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.

Authors:  Raj G Vaghjiani; Yusuke Takahashi; Takashi Eguchi; Shaohua Lu; Koji Kameda; Zachary Tano; Jordan Dozier; Kay See Tan; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2020-01-30       Impact factor: 15.609

Review 2.  The imaging of small pulmonary nodules.

Authors:  Zejun Zhou; Ping Zhan; Jiajia Jin; Yafang Liu; Qian Li; Chenhui Ma; Yingying Miao; Qingqing Zhu; Panwen Tian; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

Review 3.  The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.

Authors:  Sara Volpi; Jason M Ali; Angela Tasker; Adam Peryt; Giuseppe Aresu; Aman S Coonar
Journal:  Ann Transl Med       Date:  2018-03

Review 4.  PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies.

Authors:  Matthew F Covington; Bhasker R Koppula; Gabriel C Fine; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

5.  Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma.

Authors:  Kasia Czarnecka-Kujawa; Marc de Perrot; Shaf Keshavjee; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

6.  A new approach to predict lymph node metastasis in solid lung adenocarcinoma: a radiomics nomogram.

Authors:  Xinguan Yang; Xiaohuan Pan; Hui Liu; Dashan Gao; Jianxing He; Wenhua Liang; Yubao Guan
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 7.  PET/CT imaging in lung cancer: indications and findings.

Authors:  Bruno Hochhegger; Giordano Rafael Tronco Alves; Klaus Loureiro Irion; Carlos Cezar Fritscher; Leandro Genehr Fritscher; Natália Henz Concatto; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

8.  FDG-PET parameters predicting mediastinal malignancy in lung cancer.

Authors:  M Serra Fortuny; M Gallego; Ll Berna; C Montón; L Vigil; M J Masdeu; A Fernández-Villar; M I Botana; R Cordovilla; R García-Luján; E Cases; E Monsó
Journal:  BMC Pulm Med       Date:  2016-12-08       Impact factor: 3.317

9.  Ratio of lymph node to primary tumor SUVmax multiplied by maximal tumor diameter on positron emission tomography/integrated computed tomography may be a predictor of mediastinal lymph node malignancy in lung cancer.

Authors:  Yi Liu; Yanhua Tang; Zhiqiang Xue; Ping Yang; Kefeng Ma; Guangyu Ma; Xiangyang Chu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.

Authors:  Xue Sha; Guanzhong Gong; Qingtao Qiu; Jinghao Duan; Dengwang Li; Yong Yin
Journal:  BMC Med Imaging       Date:  2020-02-05       Impact factor: 1.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.